Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti-dyslipidemic effects and can also ameliorate NAFLD. Thus, BBR might exert its therapeutic effect on NAFLD by improving glucoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Li, Cang, Zhen, Sun, Honglin, Nie, Xiaomin, Wang, Ningjian, Lu, Yingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329945/
https://www.ncbi.nlm.nih.gov/pubmed/28241817
http://dx.doi.org/10.1186/s12902-017-0165-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329945/
https://www.ncbi.nlm.nih.gov/pubmed/28241817
http://dx.doi.org/10.1186/s12902-017-0165-7

Ejemplares similares